Latest Ovarian Cancer Diagnostics News

Page 2 of 2

Cleo Diagnostics Advances Ovarian Cancer Test with U.S. Trials and Strong Cash Position

Cleo Diagnostics reports steady progress in its U.S. and Australian clinical trials for an ovarian cancer blood test, maintaining a solid cash reserve of A$7.3 million as it prepares for FDA submission.

Ada Torres

31 Jan 2025

Top